Jorge Hurtado: La Hoja de Coca

Scientific concepts, discoveries, and nature/culture phenomena presented

1) Coca leaf chemistry and pharmacology

Active ingredient distinction

The speaker argues that the harmful effects associated with “cocaine” depend on chemical form:

• Benzoylecgonine is presented as the coca plant’s active principle.
• Cocaine hydrochloride is described as a chemically modified molecule with different properties.

Molecular / pharmacokinetic claim

• Cocaine hydrochloride is described as water-soluble, making it more diffusible in the body.
• The lecture contrasts water-soluble vs. lipid-soluble behaviors (diffusion, onset, and duration) and links this to route of administration.

Crack vs. cocaine hydrochloride (technology/chemistry link)

• “Crack” is described as a form made to be smoked rather than injected or snorted.
• The speaker claims smoking suitability depends on the compound’s chemical stability under heat, contrasting it with the hydrochloride salt form.

---

2) Anesthesia and medical revolution (derived from coca/cocaine history)

1884 ophthalmic use

• Cocaine is described as being successfully applied to the eye in 1884, starting an era of local anesthesia.

Birth of nerve block / spinal anesthesia (later development)

• The speaker states that roughly 85 years after cocaine’s discovery, injections enabled nerve blocks (including anesthesia “from the lower spine down”), used for childbirth.

Pain-relief “monopoly” framing

• The talk emphasizes how modern medicine may limit access to certain plant-derived analgesics, contrasting older methods with newer pharmaceuticals.

---

3) Procaine as a synthetic derivative

1905 procaine emergence

• The speaker describes procaine as the first synthetic derivative of cocaine (same general functional group, altered structure).

Medical / cultural claims about procaine

• Procaine is discussed as an anesthetic and is even claimed to improve joint function (e.g., arthritis).
• The lecture also frames procaine as part of “revitalizing” products.

---

4) Coca as a long-standing biological/cultural practice

Archaeological and longevity claims

• The speaker asserts about 5,000 years of archaeological evidence for coca consumption by Andean peoples.
• Radiocarbon dating is mentioned as supporting long-term chewing use.

Health and anthropology framing

• Coca chewing is described as integrated into labor life (e.g., fields/mines), similar to breaks with coffee or yerba mate.

Scale of use

• A claim is made of about 8 million coca chewers in Bolivia and Peru (farmers and miners).

---

5) Nutrition and physiology studies (as presented by the speaker)

Nutritional composition claims

The speaker claims coca leaf contains substantial amounts of:

• Protein (~18%)
• Calcium (reported as far exceeding milk)
• Phosphorus
• Vitamin A

Physiological effects at altitude

The speaker claims studies found coca chewing:

• improves oxygenation
• improves glucose utilization
• decreases blood viscosity (linked to altitude effects)
• does not reduce overall food intake

UN study controversy

• The speaker says a UN-led (or UN-associated) health study concluded coca chewing was beneficial.
• They claim the study was later vetoed/cut off due to US pressure.

---

6) Cocaine/coca prohibition and policy mechanisms (treated as a “scientific” controversy)

“Legal cocaine club” (policy structure)

• The speaker claims prohibition functions as segregation, with only a subset of countries allowed to produce coca/cocaine for medical/research/industrial purposes.
• Mentions about 36 countries, tied to International Narcotics Control / UN reporting.

1961 Single Convention (legal citations as described)

• Article 27 is described as allowing cultivation/marketing of coca for production of a “soporific” (the speaker links this to coca flavoring and Coca-Cola).
• Article 49 is described as eventually prohibiting coca chewing after a time window.

Monopoly / patents framing

The lecture argues that pharmaceutical companies influence:

• the validity of research
• access to drugs
• drug classification

It also claims patents incentivize renaming/repackaging molecules to maintain royalties.

---

7) Mariani wine → Coca-Cola origin story (historical/cultural claims with biochemical elements)

Mariani wine

• Claimed to contain coca extract and cocaine (a dosage example is mentioned).

Coca-Cola formulation logic (as described)

The talk claims Coca-Cola’s success came from:

• stimulant synergy from coca + kola nut caffeine + theobromine
• taste changes after removing alcohol, achieved by adding many other chemical ingredients

Religious / political anecdotes

• Pope Leo X and European elites are cited as consumers/advocates in the narrative.

---

8) Coca chewing technique and dose-control method (methodology-like content)

Traditional preparation / chewing

• Coca leaf preparation: remove hard parts to avoid injury.
• Chewing is described as soaking about 5–10 grams with an alkalizing agent.
• The speaker claims alkalization hydrolyzes “leonin” to reduce potentially toxic properties.

Proposed alternative administration (“coca candies/pills,” called “haj”)

• Goal: provide more controlled delivery of active alkaloids than uncontrolled chewing.
• The speaker cites a university collaboration (claiming help from Utrecht, Netherlands) to create a hard candy/stone-like consistency for slower assimilation.

Clinical monitoring approach (as described)

• Outpatient patients selected for follow-up.
• Monitoring via:
  • psychiatric criteria/assessments
  • real-world outcomes (working/studying, mental improvement)
  • collateral information from family/friends/neighbors
• Uses alkaloid dosing amounts (e.g., 12.5 mg alkaloid; “not cocaine” as framed by the speaker) and reports continued acceptance and about 1-year follow-up.

---

Researchers / sources featured (explicitly mentioned)

• Jorge Hurtado (speaker)
• Sigmund Freud
• “Places Marks” (name appears garbled/unclear; described as a colleague performing an experiment after Freud’s recommendation)
• Merck (German company producing cocaine industrially; not an individual researcher)
• Aldous (name unclear in the transcript; described as connected to Freud’s 1884 eye application)
• Freud’s discussion references: a seminar in Austria (no individual named)
• Anthony Germán (author of Mamá Coca)
• Universidad Mayor de San Andrés
• French Technical Cooperation
• University of Utrecht
• World Health Organization (WHO) (referenced for criticizing/criminalizing coca; no individual named)
• United Nations (referenced; includes International Narcotics Control Board)
• International Narcotics Control Board (INCB) (referenced via UN reporting)
• Mr. Pemberton (Coca-Cola founder; pharmacist from Atlanta)
• World Congress on Pain (Barcelona, 2004/2006 mentioned; no individual named)
• Caracas University chemistry faculty / University of Caracas (institution; individual not named)
• Anna Slam (named; procaine-related claim—identity uncertain due to subtitle quality)
• Frankfurt prosecutor (only “the prosecutor” named; no personal name given)
• Evo’s government (political source, not a researcher)

---

Summary

The video argues that coca (and its chemistry) has been historically and medically important—especially for pain control and anesthesia—and emphasizes differences between coca compounds and cocaine hydrochloride/crack forms. It also presents a controversial thesis that prohibition policies restrict access to useful plant-based medicines. Additionally, it describes alleged nutritional/physiological benefits of traditional coca chewing and outlines, from the speaker’s perspective, an experimental clinical approach using coca extracts/candies with monitoring in outpatients.